Telomir Pharmaceuticals (TELO) Institutional Ownership $4.54 +0.31 (+7.33%) Closing price 04:00 PM EasternExtended Trading$4.28 -0.26 (-5.81%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$3.98MNumber ofInstitutional Sellers(last 12 months)0 Get TELO Insider Trade Alerts Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TELO Institutional Buying and Selling by Quarter Remove Ads Telomir Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Nuveen Asset Management LLC24,990$103K0.0%N/A0.084% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036% 2/17/2025 Gotham Asset Management LLC6,770$28K0.0%N/A0.023% 2/17/2025 Bank of America Corp DE14,713$61K0.0%+283.9%0.049% 2/14/2025 Northern Trust Corp151,628$625K0.0%+211.5%0.510% 2/14/2025 Transce3nd LLC28,803$119K0.0%N/A0.097% 2/13/2025 Barclays PLC29,959$123K0.0%+326.9%0.101% 2/13/2025 Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034% 2/12/2025 Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390% 2/12/2025 JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139% 2/11/2025 Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032% 2/11/2025 Virtu Financial LLC14,959$62K0.0%N/A0.050% 2/6/2025 Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157% 2/4/2025 Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244% 1/30/2025 Rhumbline Advisers8,600$35K0.0%+105.9%0.029% 11/19/2024 Barclays PLC7,018$45K0.0%+325.1%0.024% 11/16/2024 Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806% 11/15/2024 Barclays PLC7,018$45K0.0%+325.1%0.024% 11/15/2024 State Street Corp36,094$232K0.0%+99.1%0.122% 10/21/2024 Suncoast Equity Management51,194$329K0.0%+109.9%0.173% 8/15/2024 Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049% 7/26/2024 Bank of New York Mellon Corp50,165$241K0.0%N/A0.169% 5/2/2024 Suncoast Equity Management24,391$126K0.0%N/A0.082% (Data available from 1/1/2016 forward)Remove Ads TELO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TELO shares? During the previous two years, 18 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($298K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on TELO's institutional investors. Which institutional investors have been buying Telomir Pharmaceuticals stock? Of the 18 institutional investors that purchased Telomir Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($71.10K), Suncoast Equity Management ($51.19K), JPMorgan Chase & Co. ($37.98K), Charles Schwab Investment Management Inc. ($35.56K), and Barclays PLC ($33.68K). How much institutional buying is happening at Telomir Pharmaceuticals? Institutional investors have bought a total of 821,679 shares in the last 24 months. This purchase volume represents approximately $3.98M in transactions. Related Companies Precigen Major Shareholders GH Research Major Shareholders Cullinan Therapeutics Major Shareholders Autolus Therapeutics Major Shareholders ABIVAX Société Anonyme Major Shareholders Ginkgo Bioworks Major Shareholders Chimerix Major Shareholders Keros Therapeutics Major Shareholders Sage Therapeutics Major Shareholders Mineralys Therapeutics Major Shareholders This page (NASDAQ:TELO) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.